Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ILLUMINATE: Torcetrapib/Atorvastatin in CHD
NCT00134264Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Jul 2004
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of torcetrapib in coronary heart disease (CHD), sponsored by Pfizer. Started Jul 2004; status: terminated.
02
Drugs
torcetrapib
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT00134264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00134264.